Roche Diagnostics is collaborating with the University of Liverpool to launch the Eye Cancer Artificial Intelligence Digital Bioresource (EYE-CAN-AID), a multi-modal image database that aims to boost ...

This week the University of Liverpool launched the Eye Cancer Artificial Intelligence Digital Bioresource (EYE-CAN-AID), an ...

The funds will go towards scaling C2N Diagnostics’ laboratory services and advancing the company’s range of diagnostic tests.

A multinational healthcare company, Roche and a provider of digital integrated healthcare services, Oncopadi Technologies ...

Roche and Zealand reason petrelintide could deliver weight loss comparable to glucagon-like peptide 1 (GLP-1) receptor ...

The National Institute for Cancer Research and Treatment (NICRAT) in partnership with a Roche, multinational healthcare ...

The POC Diagnostics Market is expected to grow from an estimated USD 51.26 billion in 2024 to USD 118.91 billion in 2033, at a CAGR of 9.8%. The global point-of-care (POC) diagnostics market is ...

Basel: Roche has announced that it has entered into an exclusive collaboration and licensing agreement with Zealand Pharma.

Roche has announced the launch of the Roche Genentech Innovation Center Boston, which will serve as the company’s CVRM hub.

The programme aims to enhance early detection and ensure timely, accurate breast cancer diagnosis by offering free immunohistochemistry tests, multidisciplinary care, and navigation services to 5,000 ...

A University of Rochester Medical Center study showed that downtime in the emergency room can have a potential upside for ...

The hub has also been created to strengthen an existing relationship between Harvard and Roche that has been in place for over a decade.